Successful MDR-TB treatment regimens including Amikacin are associated with high rates of hearing loss

BACKGROUND: Aminoglycosides are a critical component of multidrug-resistant tuberculosis (MDR-TB) treatment but data on their efficacy and adverse effects in Botswana is scarce. We determined the effect of amikacin on treatment outcomes and development of hearing loss in MDR-TB patients. METHODS: Pa...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:BMC Infect Dis
Autors principals: Modongo, Chawangwa, Sobota, Rafal S, Kesenogile, Boikobo, Ncube, Ronald, Sirugo, Giorgio, Williams, Scott M, Zetola, Nicola M
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2014
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4287509/
https://ncbi.nlm.nih.gov/pubmed/25300708
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2334-14-542
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars